$496 Million is the total value of Integral Health Asset Management, LLC's 71 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 85.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | Buy | ELEVANCE HEALTH INC | $23,450,310 | +82.9% | 51,000 | +104.0% | 4.72% | +75.5% |
| CYTK | Buy | CYTOKINETICS INC | $21,114,000 | +15.2% | 600,000 | +50.0% | 4.25% | +10.6% |
| INSP | Buy | INSPIRE MED SYS INC | $18,725,600 | +23.9% | 80,000 | +33.3% | 3.77% | +18.9% |
| COO | Buy | COOPER COS INC | $14,934,400 | +201.1% | 40,000 | +166.7% | 3.01% | +189.0% |
| SYK | New | STRYKER CORPORATION | $14,273,500 | – | 50,000 | +100.0% | 2.88% | – |
| ABBV | Buy | ABBVIE INC | $12,908,970 | +59.8% | 81,000 | +62.0% | 2.60% | +53.3% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $12,681,900 | +35.8% | 770,000 | +23.2% | 2.56% | +30.4% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $12,106,215 | +114.6% | 727,100 | +21.2% | 2.44% | +106.0% |
| HCA | Buy | HCA HEALTHCARE INC | $11,865,600 | +15.0% | 45,000 | +4.7% | 2.39% | +10.3% |
| TFX | Buy | TELEFLEX INCORPORATED | $11,652,260 | +133.4% | 46,000 | +130.0% | 2.35% | +124.0% |
| CAH | Buy | CARDINAL HEALTH INC | $11,476,000 | +77.7% | 152,000 | +81.0% | 2.31% | +70.6% |
| PKI | New | PERKINELMER INC | $11,327,100 | – | 85,000 | +100.0% | 2.28% | – |
| BIIB | New | BIOGEN INC | $11,121,200 | – | 40,000 | +100.0% | 2.24% | – |
| EXAS | Sell | EXACT SCIENCES CORP | $10,985,220 | -19.3% | 162,000 | -41.1% | 2.21% | -22.6% |
| New | SAREPTA THERAPEUTICS INCput | $10,337,250 | – | 75,000 | +100.0% | 2.08% | – | |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $10,320,000 | -31.7% | 600,000 | -20.0% | 2.08% | -34.4% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $10,280,200 | -25.1% | 245,000 | -31.9% | 2.07% | -28.1% |
| QURE | Sell | UNIQURE NV | $10,070,000 | -19.2% | 500,000 | -9.1% | 2.03% | -22.5% |
| IDXX | New | IDEXX LABS INC | $10,001,600 | – | 20,000 | +100.0% | 2.02% | – |
| PEN | Buy | PENUMBRA INC | $9,754,150 | +46.2% | 35,000 | +16.7% | 1.96% | +40.3% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $9,724,000 | -44.7% | 100,000 | -41.2% | 1.96% | -47.0% |
| Buy | VENTYX BIOSCIENCES INC | $9,715,000 | +41.1% | 290,000 | +38.1% | 1.96% | +35.4% | |
| HUM | New | HUMANA INC | $9,709,200 | – | 20,000 | +100.0% | 1.96% | – |
| MRK | Sell | MERCK & CO INC | $9,575,100 | -42.5% | 90,000 | -40.0% | 1.93% | -44.8% |
| PTCT | Buy | PTC THERAPEUTICS INC | $8,622,320 | +125.9% | 178,000 | +78.0% | 1.74% | +116.9% |
| GH | Sell | GUARDANT HEALTH INC | $8,204,000 | -36.5% | 350,000 | -26.3% | 1.65% | -39.0% |
| BAX | New | BAXTER INTL INC | $8,112,000 | – | 200,000 | +100.0% | 1.63% | – |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $8,052,500 | +81.8% | 250,000 | +4.2% | 1.62% | +74.4% |
| BSX | New | BOSTON SCIENTIFIC CORP | $7,604,560 | – | 152,000 | +100.0% | 1.53% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $7,472,700 | – | 345,000 | +100.0% | 1.50% | – |
| ALGN | New | ALIGN TECHNOLOGY INC | $7,351,080 | – | 22,000 | +100.0% | 1.48% | – |
| REPL | Buy | REPLIMUNE GROUP INC | $6,975,700 | +16.6% | 395,000 | +79.5% | 1.40% | +11.9% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $6,805,100 | -25.3% | 85,000 | -26.1% | 1.37% | -28.3% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $6,455,320 | +99.9% | 71,000 | -16.5% | 1.30% | +91.7% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $6,213,760 | +84.5% | 152,000 | +52.0% | 1.25% | +77.1% |
| NARI | New | INARI MED INC | $6,174,000 | – | 100,000 | +100.0% | 1.24% | – |
| HOLX | New | HOLOGIC INC | $6,052,500 | – | 75,000 | +100.0% | 1.22% | – |
| MRNA | Sell | MODERNA INC | $5,375,300 | -70.1% | 35,000 | -65.0% | 1.08% | -71.3% |
| LFST | New | LIFESTANCE HEALTH GROUP INC | $5,267,870 | – | 709,000 | +100.0% | 1.06% | – |
| ALKS | New | ALKERMES PLC | $5,046,010 | – | 179,000 | +100.0% | 1.02% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $4,892,610 | – | 213,000 | +100.0% | 0.99% | – |
| LH | New | LABORATORY CORP AMER HLDGS | $4,588,400 | – | 20,000 | +100.0% | 0.92% | – |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $4,528,750 | +217.4% | 125,000 | +212.5% | 0.91% | +205.0% |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $4,523,000 | – | 100,000 | +100.0% | 0.91% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $4,470,960 | +18.0% | 12,000 | +20.0% | 0.90% | +13.3% |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $4,407,250 | – | 61,000 | +100.0% | 0.89% | – |
| SGRY | New | SURGERY PARTNERS INC | $4,205,340 | – | 122,000 | +100.0% | 0.85% | – |
| NTRA | Sell | NATERA INC | $4,164,000 | +19.1% | 75,000 | -13.8% | 0.84% | +14.3% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $4,006,400 | -51.8% | 20,000 | -42.9% | 0.81% | -53.8% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $3,720,900 | +98.6% | 30,000 | +50.0% | 0.75% | +90.8% |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $3,518,800 | -23.3% | 152,000 | -13.1% | 0.71% | -26.3% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $3,382,450 | -15.3% | 305,000 | -6.7% | 0.68% | -18.7% |
| CTLT | New | CATALENT INC | $3,285,500 | – | 50,000 | +100.0% | 0.66% | – |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $3,219,600 | +46.3% | 30,000 | +50.0% | 0.65% | +40.5% |
| OPCH | New | OPTION CARE HEALTH INC | $3,208,770 | – | 101,000 | +100.0% | 0.65% | – |
| AKRO | AKERO THERAPEUTICS INC | $2,678,200 | -30.2% | 70,000 | 0.0% | 0.54% | -32.9% | |
| REGN | New | REGENERON PHARMACEUTICALS | $2,465,010 | – | 3,000 | +100.0% | 0.50% | – |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $2,449,800 | -53.5% | 180,000 | -33.3% | 0.49% | -55.4% |
| LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $2,333,820 | +194.6% | 582,000 | +139.5% | 0.47% | +183.1% |
| KROS | Sell | KEROS THERAPEUTICS INC | $2,135,000 | -25.9% | 50,000 | -16.7% | 0.43% | -28.9% |
| New | ACLARIS THERAPEUTICS INCcall | $2,022,500 | – | 250,000 | +100.0% | 0.41% | – | |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $2,000,700 | – | 405,000 | +100.0% | 0.40% | – |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $1,919,760 | – | 152,000 | +100.0% | 0.39% | – |
| FGEN | Sell | FIBROGEN INC | $1,903,320 | -32.1% | 102,000 | -41.7% | 0.38% | -34.9% |
| New | MERUS N Vcall | $1,840,000 | – | 100,000 | +100.0% | 0.37% | – | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $1,820,250 | -68.8% | 225,000 | -39.2% | 0.37% | -70.0% |
| GDRX | New | GOODRX HLDGS INC | $1,268,750 | – | 203,000 | +100.0% | 0.26% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $1,184,000 | – | 100,000 | +100.0% | 0.24% | – |
| New | NUVALENT INCput | $913,150 | – | 35,000 | +100.0% | 0.18% | – | |
| New | EXSCIENTIA PLCads | $805,600 | – | 152,000 | +100.0% | 0.16% | – | |
| DYN | New | DYNE THERAPEUTICS INC | $656,640 | – | 57,000 | +100.0% | 0.13% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -416,000 | -100.0% | -0.03% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.37% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -109,000 | -100.0% | -0.45% | – |
| DVA | Exit | DAVITA INC | $0 | – | -33,000 | -100.0% | -0.52% | – |
| KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.52% | – |
| PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -130,000 | -100.0% | -0.62% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -109,000 | -100.0% | -0.91% | – |
| DOCS | Exit | DOXIMITY INCcl a | $0 | – | -131,000 | -100.0% | -0.92% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -125,000 | -100.0% | -0.98% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -1.10% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -100,000 | -100.0% | -1.72% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -65,000 | -100.0% | -1.74% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -140,000 | -100.0% | -1.99% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -200,000 | -100.0% | -2.03% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -120,000 | -100.0% | -2.16% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -44,000 | -100.0% | -2.45% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -100,000 | -100.0% | -2.96% | – |
| Exit | MADRIGAL PHARMACEUTICALS INCput | $0 | – | -50,000 | -100.0% | -3.05% | – | |
| CI | Exit | CIGNA CORP NEW | $0 | – | -45,000 | -100.0% | -3.13% | – |
| DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -100,000 | -100.0% | -3.28% | – |
| Exit | CYTOKINETICS INCcall | $0 | – | -400,000 | -100.0% | -3.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.